advertisement

WGA Rescources

Advances in Therapy 27

Showing records 1 to 25 | Display all abstracts in Advances in Therapy

91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Konstas AG
Advances in Therapy 2021; 38: 24-51
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Inatani M
Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Inatani M
Advances in Therapy 2021; 38: 1106-1115
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Schmetterer L
Advances in Therapy 2021; 38: 24-51
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Higashide T
Advances in Therapy 2021; 38: 1106-1115
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Higashide T; Matsushita K
Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Matsushita K
Advances in Therapy 2021; 38: 1106-1115
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Katsanos A
Advances in Therapy 2021; 38: 24-51
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Miki A
Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Nagasato D
Advances in Therapy 2021; 38: 1106-1115
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Hutnik CML; Holló G
Advances in Therapy 2021; 38: 24-51
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Takagi H
Advances in Therapy 2021; 38: 1106-1115
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Ueki M
Advances in Therapy 2021; 38: 1116-1129
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Quaranta L
Advances in Therapy 2021; 38: 24-51
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Iwamoto Y
Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Ueki M; Takai Y
Advances in Therapy 2021; 38: 1106-1115
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Teus MA
Advances in Therapy 2021; 38: 24-51
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Kobayashi M; Leal S
Advances in Therapy 2021; 38: 1116-1129
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Uusitalo H
Advances in Therapy 2021; 38: 24-51
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Miyazaki K
Advances in Therapy 2021; 38: 1106-1115
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Leal S
Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Iwamoto Y
Advances in Therapy 2021; 38: 1106-1115
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Pfeiffer N
Advances in Therapy 2021; 38: 24-51
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial

Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Kobayashi M
Advances in Therapy 2021; 38: 1106-1115

Issue 21-4

Change Issue


advertisement

Oculus